News & Updates

Show Multimedia Only

BRIDGING KNOWLEDGE GAPS Educating frontline providers on maternal pertussis immunization

02 May 2026 by

Newborns do not receive their first vaccine against pertussis until six weeks of age. In the first weeks of life, newborns remain highly vulnerable to pertussis, with protection relying entirely from maternal antibodies transferred transplacentally acquired maternal antibodies following Tdap vaccination.

BRIDGING KNOWLEDGE GAPS Educating frontline providers on maternal pertussis immunization

02 May 2026

Nonablative radiofrequency beneficial in genitourinary syndrome of menopause

02 May 2026

Capacitive-resistive monopolar radiofrequency improves sexual function and vaginal health outcomes in women with genitourinary syndrome of menopause (GSM), as shown in a study.

Nonablative radiofrequency beneficial in genitourinary syndrome of menopause

02 May 2026

Weight cycling in adulthood linked to increased risk of gestational weight gain

29 Apr 2026

Pregnant women with a history of weight cycling as adults are likely to experience gestational weight gain, according to a study.

Weight cycling in adulthood linked to increased risk of gestational weight gain

29 Apr 2026

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

28 Apr 2026 by

Children with prenatal exposure to buprenorphine do not appear to have an elevated risk of long-term adverse neurodevelopmental outcomes relative to those exposed to methadone, suggests a study.

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

28 Apr 2026

Prepregnancy hypertension linked to negative IVF outcomes

26 Apr 2026 by

Among women undergoing in vitro fertilization (IVF) treatment, those who have stage 1 or 2 hypertension prior to the initiation of ovarian stimulation may have reduced chances of a live birth and increased risks of pregnancy complications, according to a large retrospective study.

Prepregnancy hypertension linked to negative IVF outcomes

26 Apr 2026

Novel neurokinin 3 receptor antagonist for VMS clears phase II study

25 Apr 2026

Treatment with the neurokinin 3 receptor antagonist GS1-144 appears to help reduce the frequency and severity of vasomotor symptoms (VMS) in postmenopausal Chinese women, according to a phase II study.

Novel neurokinin 3 receptor antagonist for VMS clears phase II study

25 Apr 2026

Maternal obesity may elevate bile acids in breast milk

24 Apr 2026

Maternal obesity appears to increase bile acid (BA) levels in breast milk, which may have implications for neonatal digestion, maturation, and health.